Illness	Number of cases
Malignant neoplasm of breast (C50.9)	416
Malignant neoplasm of breast (C50.4)	301
Carcinoma in situ of breast (D05.1)	141
Malignant neoplasm of breast (C50.2)	118
Malignant neoplasm of breast (C50.5)	73
Malignant neoplasm of breast (C50.3)	46
Benign neoplasm of breast (D24)	46
Hypertrophy of breast (N62)	40
Malignant neoplasm of breast (C50.8)	37
Secondary malignant neoplasm of respiratory and digestive organs - Secondary malignant neoplasm of liver and intrahepatic bile duct (C78.7)	31

Top 10 treatments

Treatment	Number
Gamma probe measurement when removing a particular lymph node in cancerous diseases, e.g. with breast cancer (3-760)	443
Surgical removal of individual lymph nodes or lymphatic vessels (5-401.13)	421
Breast-conserving surgical removal of breast tissue, without taking the axillary lymph nodes (5-870.a1)	402
Complex differential diagnostic sonography of soft tissue tumours with quantitative measurement (3-036)	318
Revision operations (5-983)	274
Breast-conserving surgical removal of breast tissue, without taking the axillary lymph nodes (5-870.a0)	217
Treatment procedures requiring dyes (5-989)	189
Surgical removal of individual lymph nodes or lymphatic vessels (5-401.12)	186
Surgical removal of the breast (mastectomy), without taking the axillary lymph nodes (5-872.1)	154
Breast-conserving surgical removal of breast tissue, without taking the axillary lymph nodes (5-870.a2)	113

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2400

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Brustkrebs

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ31

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
154	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
105	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
105	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Doctoral supervision
Student training (clinical traineeship / internship year)
Participation in multi-centre phase III/IV studies
Lectureships / teaching posts at colleges and universities

Training

No.	Training in other healing professions	Comment
HB19	Nursing professionals
HB01	Nurse and health care worker (m/f)
HB12	Medical technical laboratory assistant (MTLA) (m/f)
HB05	Medical technical radiology assistant (MTRA) (m/f)
HB07	Surgical technical assistant (m/f)
HB15	Anaesthesia technical assistant (m/f)